Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2020 | Myeloproliferative neoplasms in young patients

Nicole Kucine • 25 Aug 2020
Texas MPN Workshop 2020
Acute Myeloid Leukemia Essential Thrombocythemia Leukemia Myeloproliferative Neoplasms Polycythemia Vera Rare Diseases Interferon

Nicole Kucine, MD, MS, of Weill Cornell Medicine, New York, NY, discusses the incidence of myeloproliferative neoplasms in adolescent and pediatric patients, and differences in genetic profiles, treatment and outcomes between adult and younger patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Nicole Kucine

4:04
Updates on the treatment of pediatric and AYA patients with MPNs
Nicole Kucine • 10 Aug 2021
3:09
Pegylated interferon for the treatment of polycythemia vera and essential thrombocythemia
Nicole Kucine • 10 Aug 2021
3:55
Unmet needs in the treatment of pediatric/adolescent MPN
Nicole Kucine • 25 Aug 2020
2:08
Looking forward to the Texas MPN Workshop 2020
Nicole Kucine • 25 Aug 2020

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals